COVID-19
Topic
Check out the latest COVID-19 news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
LATEST COVID-19 NEWS
ScoPo’s (actually still Iain’s) Powerplays: ASX health sector falls, but several stocks on upward run
Monsters of Rock: Some of these booming lithium exploration stocks are creeping up on us
Monsters of Rock: Hoping for an end to China’s lockdowns, metal heads? Don’t count on it
Dr Boreham’s Crucible: Three out of four quarters says trust your about gut about Genetic Signatures
Interim results show MGC Pharma’s CimetrA dose finding study on right track
Once shunned, Viva Leisure and these ASX stocks are making a comeback post-Covid
CLARITY 2.0 Covid-19 study involving Dimerix’s lead drug concludes patient recruitment
‘Revenues and profitability will steadily increase’: Equity firm says undervalued EZZ set up for future growth
Closing Bell: Tech takes control as Asia Pacific markets rise en masse
MGC Pharma’s shares spike more than 20pc on positive trial of ArtemiC Support into Long Covid
Data analysis of COVID-19 study using Dimerix’ treatment DMX-200 is officially under way
Medlab wants to get right up COVID’s nose, as nasal vaccine program gathers steam
Dimerix hits more key milestones in Q3, as major global trials across its core product suite continue to advance
